A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an escalating controversy over an advertisement that aired during the 2025 ...

There’s a full-blown war over copycat versions of blockbuster obesity drugs. But their days are likely numbered. During ...

Hims & Hers has capitalized on the outsize consumer demand for obesity drugs. (Hims & Hers Health) Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom ...

Hims & Hers hit the bullseye with its Super Bowl ad, sparking a surge in clicks to its site. The ad also hit a nerve with the pharma industry, lawmakers and some industry groups. The ad, called "Sick ...

The telehealth company is being criticized for its Super Bowl weight loss commercial. (Hims & Hers via YouTube) During the Super Bowl, Hims & Hers Health aired a commercial called “Sick of the System.

Drug industry allies are calling out a Super Bowl ad touting its weight loss medications from telehealth company Hims & Hers, claiming the spot doesn't adequately disclose safety risks of these drugs.

Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that's slated to run during the Super Bowl on Sunday. Stream NBC 5 for free, 24/7, wherever you are.

Hims & Hers Health's (NYSE: HIMS) share price has surged recently, climbing above $60 and creating new 52-week and all-time ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Hims & Hers sells a compounded weight loss medication. A telehealth company that sells a compounded version of medications used for weight loss has found itself at the center of an escalating ...